Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours. (BANN)
This study has been completed.
Study NCT01398306 Information provided by University Medical Centre Groningen
First Received on July 19, 2011. Last Updated on May 7, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Carcinoma
Carcinoma, Renal Cell
Neuroendocrine Tumors
Carcinoid Tumor
Pancreatic Islet Cell Tumors
Additional conditions recognized in this trial
Adenoma, Islet Cell
Endocrine Gland Neoplasms
More general conditions related to this trial
Adenocarcinoma
Adenoma
Digestive System Diseases
Digestive System Neoplasms
Endocrine System Diseases
Kidney Diseases
Kidney Neoplasms
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neuroectodermal Tumors
Pancreatic Diseases
Pancreatic Neoplasms
Urogenital Neoplasms
Urologic Diseases
Urologic Neoplasms
Interventions listed in this trial
Blood sampling by vena punction.
Additional drug interventions recognized in this trial
Angiogenesis Inducing Agents
Angiogenesis Inhibitors
More general drug interventions related to this trial
Angiogenesis Modulating Agents
Antineoplastic Agents
Growth Inhibitors
Growth Substances
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
University Medical Centre Groningen
Back to top of Main Content
